We used the GENT2 database to compare the levels of CGN and PTPRR between normal and cancer tissues [Supplementary Figure 3A and B] and found that CGN is downregulated in 19/35 cancers including CRC (red brackets) while PTPRR is downregulated in 16/35 including CRC. This evidence concerns the gene CGN and cancer.